Le Lézard
Classified in: Health, Science and technology

Live Cell Imaging Market worth $4.3 billion | MarketsandMarkets


CHICAGO, May 30, 2023 /PRNewswire/ -- The live cell imaging industry is poised for significant growth and advancements in the near future. With continuous advancements in imaging technologies and the increasing importance of understanding cellular dynamics and processes in real-time, the demand for live cell imaging solutions is expected to surge. The industry will witness the development of more sophisticated imaging techniques, such as super-resolution microscopy, multi-photon microscopy, and light sheet microscopy, enabling higher resolution and deeper imaging capabilities. Additionally, the integration of live cell imaging with other technologies like artificial intelligence and machine learning will provide advanced analysis and interpretation of cellular data. Furthermore, the rising application of live cell imaging in various fields such as drug discovery, developmental biology, cancer research, and neuroscience will drive the market growth. The availability of user-friendly and cost-effective live cell imaging systems will also contribute to wider adoption across research institutions and biopharmaceutical companies. Overall, the future of the live cell imaging industry holds immense potential for ground-breaking discoveries and deeper insights into the dynamic world of cellular biology.

MarketsandMarkets_Logo

Live Cell Imaging Market in terms of revenue was estimated to be worth $2.7 billion in 2023 and is poised to reach $4.3 billion by 2028, growing at a CAGR of 10.2% from 2023 to 2028 according to a new report by MarketsandMarketstm. The global live cell imaging market is expected to grow at a CAGR of 10.2% during the forecast period. The growth of this market is driven by continuous technological advancements in live cell imaging instrumentation, including improved microscope designs, better fluorophores, and more sensitive detectors. These innovations enable enhanced imaging capabilities, better signal-to-noise ratios, and increased experimental throughput, leading to expanded applications and adoption of live cell imaging technologies.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163914483

Browse in-depth TOC on "Live Cell Imaging Market"

293 - Tables
50 - Figures
305 - Pages

Live Cell Imaging Market Scope:

Report Coverage

Details

Market Revenue in 2023

$2.7 billion

Estimated Value by 2028

$4.3 billion

Growth Rate

Poised to grow at a CAGR of 10.2%

Market Size Available for

2021?2028

Forecast Period

2023?2028

Forecast Units

Value (USD Billion)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Product & Service, Application, Technology, and End User

Geographies Covered

North America, Europe, Asia Pacific, Latin America (LATAM) and Middle East and Africa (MEA)

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Increasing adoption of live cell imaging technologies in emerging markets

Key Market Drivers

Growing availability of funds for research

 

The cell biology segment accounted for the largest share, by application in the live cell imaging market in 2022.

By application, the global live cell imaging market has been further categorized as cell biology, stem cells, developmental biology, and drug discovery. The cell biology segment held the largest share of the global live cell imaging market in 2022. This can be attributed to the increasing research activities in cell biology. Live cell imaging plays a crucial role in this research by allowing scientists to observe dynamic cellular events, such as cell division, migration, and signalling, in real-time. The increasing research activities in cell biology drive the demand for live cell imaging solutions.

The time-lapse microscopy segment accounted for the largest share of the technology segment in the live cell imaging market in 2022. 

Based on technology, the global live cell imaging market has been segmented into time-lapse microscopy, fluorescence resonance energy transfer (FRET), fluorescence recovery after photobleaching (FRAP), high content screening (HCS), and other technologies. The time-lapse microscopy segment held the largest market share in 2022. The large share of this segment can be attributed to the real-time visualization of cellular dynamics, advancements in imaging technologies, increasing research focus on cellular dynamics, and drug discovery applications.

The North America region catered the largest share of the live cell imaging market in 2022.

The live cell imaging market in North America has experienced significant growth in recent years, showcasing a robust expansion trajectory, owing to the well-established research infrastructure, strong pharmaceutical and biotech industry, increasing government support for life science research, technological advancements in live cell imaging, and collaborative initiatives contribute to the growth of the live cell imaging market in the North America region. Additionally, North America faces a significant burden of chronic diseases, including cancer, cardiovascular diseases, and neurological disorders. The increasing prevalence of chronic diseases in the region drives the demand for live cell imaging techniques for both research and clinical applications.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=163914483

Live Cell Imaging Market Dynamics:

Drivers:

  1. Growing adoption of high-content screening techniques in drug discovery
  2. Rising incidence of cancer
  3. Growing availability of research funds

Restraints:

  1. High cost of high-content screening systems

Opportunities:

  1. Increasing adoption of live cell imaging technologies in emerging markets
  2. Applications of HCS in personalized medicine

Challenges:

  1. Maintaining cell viability and cellular environment in cell cultures
  2. Image analysis and data management

Key Market Players:

Key players in the live cell imaging market include Danaher (US), ZEISS Group (Germany), Nikon Corporation (Japan), Olympus Corporation (Japan), PerkinElmer Inc. (US), Sartorius AG (Germany), Agilent Technologies, Inc. (US), Thermo Fisher Scientific, Inc. (US), Etaluma, Inc. (US), CytoSMART Technologies (Netherlands), NanoEnTek Inc. (South Korea), GE Healthcare (US), Bruker Corporation (US), Becton, Dickinson and Company (BD) (US), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Blue-Ray Biotech Corp. (Taiwan), CYTENA GmbH (Germany), Nanolive SA (Switzerland), Abberior (Germany), Phase Holographic Imaging (PHI) AB (Sweden), Cytoskeleton, Inc. (US), Corning Incorporated (US), KEYENCE Corporation (Japan), and Aligned Genetics, Inc. (South Korea).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=163914483

Recent Developments:

Live Cell Imaging Market Advantages:

These advantages position the live cell imaging market as a crucial tool in advancing our understanding of cellular biology, driving discoveries, and accelerating advancements in various fields of biomedical research.

Live Cell Imaging market - Report Highlights:

Related Reports:

Cell Culture Market - Global Forecasts to 2028

Microscopy Market - Global Forecasts to 2027

Cell Analysis Market - Global Forecasts to 2027

Cell-based Assays Market - Global Forecasts to 2025

Oxidative Stress Assay Market - Global Forecasts to 2025

About MarketsandMarketstm:

MarketsandMarketstm is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStoretm (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarketstm.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/live-cell-imaging-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/live-cell-imaging.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg 

 


These press releases may also interest you

at 09:55
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has been named an Edison Award Winner in the 2024 Edison Awards, for the second year in a row. Viz PE with right ventricle/left ventricle...

at 09:50
The "Targeted Sequencing Market - A Global and Regional Analysis: Focus on Application, Product Type, Target Enrichment Methods, Type of Target Capture, End User, and Region - Analysis and Forecast, 2024-2033" report has been added to...

at 09:43
Discover new ways to make your skin BLOOM! Beekman 1802's top selling skin barrier-building formula, Bloom Cream Daily Face Moisturizer, is now available in two NEW formats that will make blooming even better! Introducing the Bloom Cream in a Tube...

at 09:00
ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced the opening of A5374, a phase 1/2a study evaluating the safety, tolerability, and antiviral effect of a novel combination regimen that includes...

at 09:00
PureTalk, a nationwide cell phone service provider offering premium wireless service at a fair price on the nation's most dependable 5G network, today celebrates over $100,000 customer donations to the America's Warrior Partnership (AWP). Since...

at 09:00
Amid growing concerns about a medical crisis as a result of acute conflict between the government...



News published on and distributed by: